These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2726633)

  • 21. Malignant hyperthermia.
    Moore JL; Rice EL
    Am Fam Physician; 1992 May; 45(5):2245-51. PubMed ID: 1575119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and management of susceptibility to malignant hyperthermia in pregnancy.
    Sorosky JI; Ingardia CJ; Botti JJ
    Am J Perinatol; 1989 Jan; 6(1):46-8. PubMed ID: 2910318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is lymphocyte adenosine a diagnostic marker of clinical malignant hyperthermia? A pilot study.
    Bina S; Capacchione J; Munkhuu B; Muldoon S; Bünger R
    Crit Care Med; 2015 Mar; 43(3):584-93. PubMed ID: 25479114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preoperative management of malignant hyperthermia].
    Migita T; Kawamoto M
    Masui; 2010 Sep; 59(9):1138-41. PubMed ID: 20857669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant hyperthermia.
    Nissen RL; Yonkers AJ
    Laryngoscope; 1982 Oct; 92(10 Pt 1):1183-6. PubMed ID: 6290807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro diagnosis of malignant hyperpyrexia syndrome].
    Eldar I; Goldberg G; Glauber V; Perel A
    Harefuah; 1991 Dec; 121(12):499-502. PubMed ID: 1794753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant hyperthermia susceptibility: anaesthetic implications and risk stratification.
    Ben Abraham R; Cahana A; Krivosic-Horber RM; Perel A
    QJM; 1997 Jan; 90(1):13-8. PubMed ID: 9093584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of otolaryngic patients susceptible to malignant hyperthermia without dantrolene.
    Derkay CS; Grundfast KM
    Otolaryngol Head Neck Surg; 1991 Nov; 105(5):680-6. PubMed ID: 1754251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current concepts. The malignant hyperthermia syndrome.
    Nelson TE; Flewellen EH
    N Engl J Med; 1983 Aug; 309(7):416-8. PubMed ID: 6348539
    [No Abstract]   [Full Text] [Related]  

  • 30. Educational computer simulation of malignant hyperthermia.
    Schwid HA; O'Donnell D
    J Clin Monit; 1992 Jul; 8(3):201-8. PubMed ID: 1494926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
    Harrison GG
    Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Postoperative hyperthermic syndrome with a questionable relationship to malignant hyperthermia and the need for elucidating susceptibility].
    Plötz J
    Anaesthesist; 1986 Dec; 35(12):751-4. PubMed ID: 3826611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Screening tests for malignant hyperthermia susceptibility].
    Krivosic-Horber R; Adnet P
    Ann Fr Anesth Reanim; 1989; 8(5):444-56. PubMed ID: 2560612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A blinded comparison of noninvasive, in vivo phosphorus nuclear magnetic resonance spectroscopy and the in vitro halothane/caffeine contracture test in the evaluation of malignant hyperthermia susceptibility.
    Olgin J; Rosenberg H; Allen G; Seestedt R; Chance B
    Anesth Analg; 1991 Jan; 72(1):36-47. PubMed ID: 1984374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrodiagnostic tests in the detection of malignant hyperthermia.
    Eng GD; Becker MJ; Muldoon SM
    Muscle Nerve; 1984 Oct; 7(8):618-25. PubMed ID: 6543907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant hyperthermia, a Scandinavian update.
    Broman M; Islander G; Müller CR
    Acta Anaesthesiol Scand; 2015 Sep; 59(8):951-61. PubMed ID: 25989378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant hyperthermia: clinical and molecular aspects.
    Correia AC; Silva PC; da Silva BA
    Rev Bras Anestesiol; 2012; 62(6):820-37. PubMed ID: 23176990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current concepts of malignant hyperthermia.
    Jafek BW; Solomons CC; Masson NC; Mahowald MC; Gumprecht TF
    Otolaryngol Head Neck Surg; 1981; 89(6):891-7. PubMed ID: 6801585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Porcine malignant hyperthermia: effect of dantrolene sodium on in-vitro halothane-induced contraction of susceptible muscle.
    Anderson IL; Jones EW
    Anesthesiology; 1976 Jan; 44(1):57-61. PubMed ID: 1244776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical protocol for the management of malignant hyperthermia.
    Kollmann-Camaiora A; Alsina E; Domínguez A; Del Blanco B; Yepes MJ; Guerrero JL; García A
    Rev Esp Anestesiol Reanim; 2017 Jan; 64(1):32-40. PubMed ID: 27633384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.